4 Undervalued Pharmaceuticals Stocks for Thursday, April 18
Discover the top 4 undervalued Pharmaceuticals stocks for Thursday, April 18 based on AAII’s Stock Grades.Grace Malone
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company was formerly known as PainReform Ltd. and changed its name to PRF Technologies Ltd. in January 2026. PRF Technologies Ltd. was incorporated in 2007 and is based in Tel Aviv-Yafo, Israel.
Commentary & Analysis
4 Undervalued Pharmaceuticals Stocks for Tuesday, February 27
Discover the top 4 undervalued Pharmaceuticals stocks for Tuesday, February 27 based on AAII’s Stock Grades.Grace Malone
5 Undervalued Pharmaceuticals Stocks for Thursday, December 07
Discover the top 5 undervalued Pharmaceuticals stocks for Thursday, December 07 based on AAII’s Stock Grades.Eunice Kim
Is PainReform Ltd. Stock (PRFX) a Good Investment?
Learn more about PainReform Ltd’s (PRFX) stock grades for Value, Growth and Momentum and determine whether this Pharmaceuticals stock meets your investment needs.
Adam Scheg
Financial Summary
| Share Statistics | PRFX | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $3.2 | $569.9 | 2% |
|
| Shares Out (Mil) | 0.9 | 44.8 | 4% |
|
| Institutional Ownership | na | 84.6% | na |
|
| Float (Mil) | 3.0 | 45.1 | 8% |
|
| Beta | 0.98 | 0.67 | 59% |
|
| Avg Daily Volume (000s) | 195 | 294 | 45% |
|
| Price Change (52-week) |
(85.8%) | 65.2% | 5% |
|
| Growth | PRFX | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 6.7% | na |
|
| Net Income (5yr) | (3.2%) | (2.0%) | 35% |
|
| EPS (5yr) | na | 14.9% | na |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (14.9%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | PRFX | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $230 | na |
|
| Net Income (TTM) (Mil) | ($5) | ($11) | 34% |
|
| EPS (TTM) | ($7.466) | ($0.600) | 6% |
|
| Operating Cash Flow (TTM) (Mil) | ($4) | ($6) | 26% |
|
| Net Cash Flow (TTM) (Mil) | ($1) | $4 | 40% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $7 | 0% |
|
| Enterprise Value (Q1) (Mil) | ($2) | $493 | 3% |
|
| Valuation | PRFX | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.10 | 2.89 | 1% |
|
| P/E | na | 20.6 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | PRFX | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | (311.8%) | 65.9% | 1% |
|
| Net Margin | na | (0.2%) | na |
|
| ROA | (58.6%) | (25.5%) | 10% |
|
| ROE | (93.3%) | (21.4%) | 10% |
|
| Liabilities to Assets | 22.6% | 35.5% | 15% |
|
| F-Score | 2 | 3 | 7% |
|
PRF Technologies Ltd. did not pass any screens on 7/30/2026.
